These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 37871689)

  • 1. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer.
    Zhao Y; Song Y; Zhang Y; Ji M; Hou P; Sui F
    Mol Cell Probes; 2023 Dec; 72():101940. PubMed ID: 37871689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
    Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
    J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA-mRNA regulatory network.
    Wang Y; Wang J; Jiang J; Zhang W; Sun L; Ge Q; Li C; Li X; Li X; Shi S
    Heliyon; 2024 Apr; 10(7):e28242. PubMed ID: 38601669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC).
    Qattan A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach.
    Balasundaram A; Mitra TS; Tayubi IA; Zayed H; Doss GPC
    ACS Omega; 2024 Jun; 9(23):24379-24395. PubMed ID: 38882157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
    Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
    Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
    Hu Y; Zou D
    PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Li J; Yao J
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 39027992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
    Ren Y; Feng L; Tan Z; Zhou F; Liu S
    Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning analysis identifies genes differentiating triple negative breast cancers.
    Kothari C; Osseni MA; Agbo L; Ouellette G; Déraspe M; Laviolette F; Corbeil J; Lambert JP; Diorio C; Durocher F
    Sci Rep; 2020 Jun; 10(1):10464. PubMed ID: 32591639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle apparatus coiled-coil protein 1 (SPDL1) serves as a novel prognostic biomarker in triple-negative breast cancer.
    Yang XY; Zheng XX; Zhai XJ; Tang T; Yu SC
    Proteomics Clin Appl; 2024 Jul; 18(4):e202300002. PubMed ID: 38316615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
    Li Y; Yang S; Qi L; Li Y; Wang X
    Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudogene-gene functional networks are prognostic of patient survival in breast cancer.
    Smerekanych S; Johnson TS; Huang K; Zhang Y
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):51. PubMed ID: 32241256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment.
    Sueta A; Fujiki Y; Goto-Yamaguchi L; Tomiguchi M; Yamamoto-Ibusuki M; Iwase H; Yamamoto Y
    Oncol Lett; 2021 Dec; 22(6):819. PubMed ID: 34671433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans.
    Angajala A; Raymond H; Muhammad A; Uddin Ahmed MS; Haleema S; Haque M; Wang H; Campbell M; Martini R; Karanam B; Kahn AG; Bedi D; Davis M; Tan M; Dean-Colomb W; Yates C
    Sci Rep; 2022 Dec; 12(1):22178. PubMed ID: 36550153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer.
    Xia H; Xu X; Guo Y; Deng X; Wang Y; Fu S
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer.
    Li S; Qian Y; Xie W; Li X; Wei J; Wang L; Ren G; Yin X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):149. PubMed ID: 38512527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery.
    Balkrishna A; Mittal R; Arya V
    Curr Drug Targets; 2023; 24(6):509-520. PubMed ID: 36892021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update.
    Yan LJ; Y Lau AT; Xu YM
    Epigenomics; 2024 Apr; 16(8):571-87. PubMed ID: 38639712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.